121 related articles for article (PubMed ID: 1834113)
21. Cisplatin administered by the intracavitary route as treatment for malignant mesothelioma.
Markman M; Cleary S; Pfeifle C; Howell SB
Cancer; 1986 Jul; 58(1):18-21. PubMed ID: 3708543
[TBL] [Abstract][Full Text] [Related]
22. Intrapleural administration of cisplatin (DDP) for treatment of pleural neoplasia.
Keller ET; Vail DM
J Vet Intern Med; 1992; 6(3):198-9. PubMed ID: 1619599
[No Abstract] [Full Text] [Related]
23. Prospective study of combination chemotherapy with cyclophosphamide, doxorubicin, and cisplatin for unresectable or metastatic malignant pleural mesothelioma.
Shin DM; Fossella FV; Umsawasdi T; Murphy WK; Chasen MH; Walsh G; Komaki R; McMurtrey MJ; Hong WK
Cancer; 1995 Dec; 76(11):2230-6. PubMed ID: 8635025
[TBL] [Abstract][Full Text] [Related]
24. Cisplatin pharmacokinetics in children with cancer.
Peng B; English MW; Boddy AV; Price L; Wyllie R; Pearson AD; Tilby MJ; Newell DR
Eur J Cancer; 1997 Oct; 33(11):1823-8. PubMed ID: 9470840
[TBL] [Abstract][Full Text] [Related]
25. Local recurrence model of malignant pleural mesothelioma for investigation of intrapleural treatment.
Opitz I; Lardinois D; Arni S; Hillinger S; Vogt P; Odermatt B; Rousson V; Weder W
Eur J Cardiothorac Surg; 2007 May; 31(5):773-8. PubMed ID: 17350855
[TBL] [Abstract][Full Text] [Related]
26. Clinical pharmacology of intraperitoneal cisplatin.
Lopez JA; Krikorian JG; Reich SD; Smyth RD; Lee FH; Issell BF
Gynecol Oncol; 1985 Jan; 20(1):1-9. PubMed ID: 4038390
[TBL] [Abstract][Full Text] [Related]
27. An open-label phase I pilot study of continuous intrapleural infusion of escalated doses of methotrexate in malignant pleural mesothelioma.
Ellithy MM; El Baghdady NS; El Wakeel LM; Abdeltawab KA; Badary OA
Am J Clin Oncol; 2013 Oct; 36(5):514-8. PubMed ID: 22781392
[TBL] [Abstract][Full Text] [Related]
28. Intrapleural hypotonic cisplatin treatment for malignant pleural mesothelioma: in vitro experiments and clinical application.
Tagawa T; Yoshino I; Yamaguchi M; Osoegawa A; Kameyama T; Fukuyama S; Kometani T; Maehara Y
Surg Today; 2006; 36(2):135-9. PubMed ID: 16440159
[TBL] [Abstract][Full Text] [Related]
29. A pharmacokinetic study of high-dose continuous infusion cisplatin in children with solid tumors.
Dominici C; Petrucci F; Caroli S; Alimonti A; Clerico A; Castello MA
J Clin Oncol; 1989 Jan; 7(1):100-7. PubMed ID: 2909663
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetic and pharmacodynamic analysis of platinum after combined treatment of cisplatin and procainamide hydrochloride in mice bearing P388 leukemia.
Vannozzi MO; Ottone M; Mariggiò MA; Cafaggi S; Parodi B; Cilli M; Lindup E; Viale M
Anticancer Res; 2003; 23(2B):1509-16. PubMed ID: 12820417
[TBL] [Abstract][Full Text] [Related]
31. Intrapleural polymeric films containing cisplatin for malignant pleural mesothelioma in a rat tumour model: a preliminary study.
Ampollini L; Sonvico F; Barocelli E; Cavazzoni A; Bilancia R; Mucchino C; Cantoni AM; Carbognani P
Eur J Cardiothorac Surg; 2010 Mar; 37(3):557-65. PubMed ID: 19766508
[TBL] [Abstract][Full Text] [Related]
32. Test dose-guided administration of cisplatin in an anephric patient: a case report.
Ribrag V; Droz JP; Morizet J; Leclercq B; Gouyette A; Chabot GG
Ann Oncol; 1993 Sep; 4(8):679-82. PubMed ID: 8240999
[TBL] [Abstract][Full Text] [Related]
33. Thoracic stop-flow perfusion in the treatment of refractory malignant pleural mesothelioma: a phase I-II evaluation/trial.
Guadagni S; Clementi M; Valenti M; Fiorentini G; Cantore M; Kanavos E; Amicucci G
In Vivo; 2006; 20(6A):715-8. PubMed ID: 17203752
[TBL] [Abstract][Full Text] [Related]
34. Intrapleural cisplatin and cytarabine in the management of malignant pleural effusions: a Lung Cancer Study Group trial.
Rusch VW; Figlin R; Godwin D; Piantadosi S
J Clin Oncol; 1991 Feb; 9(2):313-9. PubMed ID: 1988578
[TBL] [Abstract][Full Text] [Related]
35. Phase-II study with the combination of cisplatin and doxorubicin in advanced malignant mesothelioma of the pleura.
Henss H; Fiebig HH; Schildge J; Arnold H; Hasse J
Onkologie; 1988 Jun; 11(3):118-20. PubMed ID: 3045724
[TBL] [Abstract][Full Text] [Related]
36. Innovative therapies: intraoperative intracavitary chemotherapy.
Chang MY; Sugarbaker DJ
Thorac Surg Clin; 2004 Nov; 14(4):549-56. PubMed ID: 15559062
[TBL] [Abstract][Full Text] [Related]
37. Hypotonic intrapleural cisplatin chemotherapy as treatment for pleural carcinomatosis in an experimental model.
Katano K; Tsujitani S; Saito H; Ikeguchi M; Maeta M; Kaibara N
Anticancer Res; 1997; 17(6D):4547-52. PubMed ID: 9494566
[TBL] [Abstract][Full Text] [Related]
38. Polymeric films loaded with cisplatin for malignant pleural mesothelioma: a pharmacokinetic study in an ovine model.
Ampollini L; Barocelli E; Cavazzoni A; Petronini P; Mucchino C; Cantoni AM; Leonardi F; Ventura L; Barbieri S; Colombo P; Fusari A; Carbognani P; Rusca M; Sonvico F
J Thorac Dis; 2018 Jan; 10(Suppl 2):S207-S220. PubMed ID: 29507788
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics of cisplatin in combined cisplatin and 5-fluorouracil therapy: a comparative study of three different schedules of cisplatin administration.
Ikeda K; Terashima M; Kawamura H; Takiyama I; Koeda K; Takagane A; Sato N; Ishida K; Iwaya T; Maesawa C; Yoshinari H; Saito K
Jpn J Clin Oncol; 1998 Mar; 28(3):168-75. PubMed ID: 9614438
[TBL] [Abstract][Full Text] [Related]
40. Combined cisplatin, doxorubicin, and mitomycin for the treatment of advanced pleural mesothelioma: a phase II FONICAP trial. Italian Lung Cancer Task Force.
Pennucci MC; Ardizzoni A; Pronzato P; Fioretti M; Lanfranco C; Verna A; Giorgi G; Vigani A; Frola C; Rosso R
Cancer; 1997 May; 79(10):1897-902. PubMed ID: 9149015
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
